Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-30Clinical Trial Update: Efficacy of Intersectional Short Pulse Stimulation for Terminating Seizures [NA]
A clinical trial evaluating intersectional short pulse stimulation to terminate seizures has been withdrawn.
-
FDA approval · 2024-12-26FDA Approved: LAMOTRIGINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for lamotrigine by Amneal Pharmaceuticals LLC (ANDA 207497).
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy [NA]
A completed clinical trial indicates that incorporating multidimensional psychosocial interventions improves well-being in individuals with …
-
FDA approval · 2024-12-19FDA Approved: OXCARBAZEPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals, Inc.'s supplemental application for Oxcarbazepine.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: The Effectiveness and Safety of Vagus Nerve Stimulation for TRE
A completed clinical trial evaluated the effectiveness and safety of vagus nerve stimulation for tuberous sclerosis complex–associated epile…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2024-12-17FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)
FDA granted a supplemental approval for Vigabatrin by Actavis Pharma, Inc., updating the product under the ANDA process.
-
FDA approval · 2024-12-17FDA Approved: LEVETIRACETAM — Supplemental Application (SOHM, Inc.)
The FDA approved a supplemental application for LEVETIRACETAM submitted by SOHM, Inc.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation [NA]
A pediatric epilepsy imaging study using diffusion tensor imaging and functional connectivity correlations is currently recruiting, sponsore…
-
FDA approval · 2024-12-10FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC to modify an existing gabapentin product.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE) [EARLY_Phase 1]
This clinical trial update outlines a Phase 1 study of propranolol as an adjuvant treatment for focal refractory epilepsy, which is not yet …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Volatile Non-Invasive Biomarkers of Epileptic Seizures
A University College London Hospitals-led study is investigating volatile non-invasive biomarkers for epileptic seizures and is currently re…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Electrical Impedance Tomography of Epilepsy
Clinical trial update on using Electrical Impedance Tomography for epilepsy at University College London; the study is currently active but …
-
FDA approval · 2024-12-05FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for divalproex sodium submitted by Unichem Pharmaceuticals (USA), Inc. under ANDA079163. This ac…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.
The update summarizes the IMPACT study evaluating AspireSR VNS Therapy for epilepsy and its effects on healthcare resource utilization and c…
-
FDA approval · 2024-12-02FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc., authorizing a modification to the approved …
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Metformin Efficacy and Safety in Epileptic Patients [Phase 3]
Phase 3 trial evaluating metformin for efficacy and safety in epilepsy has completed. The snippet does not include trial results.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Exogenous Ketone Esters for Drug Resistant Epilepsy [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating exogenous ketone esters for drug-resistant epilepsy is currently recruiting at Sohag University.
-
FDA approval · 2024-11-26FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application from Micro Labs Limited for an extended-release formulation of acetazolamide.
-
FDA approval · 2024-11-26FDA Approved: TOPIRAMATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Topiramate submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Patient-reported Outcome After Status Epilepticus
A completed clinical trial update assessing patient-reported outcomes and long-term outcomes following status epilepticus, including ICU-rel…
-
FDA label_change · 2024-11-26FDA Approved: LEVETIRACETAM — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA lists a supplemental application for levetiracetam by ScieGen Pharmaceuticals, Inc. under an approved ANDA; the specific change being re…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems [NA]
Clinical trial update for a prospective vagus nerve stimulation study investigating neuromodulation of immune and gastrointestinal systems, …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning
Completed clinical trial evaluating detection of paroxysmal events using computer vision and machine learning.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
Completed clinical trial registry update describing subjects with drug-resistant epilepsy treated with the VNS Therapy System by LivaNova.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: SLC13A5 Deficiency Natural History Study - Remote Only
Remote-only natural history study of SLC13A5 deficiency is being conducted by the TESS Research Foundation. Enrollment is by invitation only…